Background The dynamic changes of lymphocyte subsets and cytokines profiles of patients
with novel coronavirus disease (COVID-19) and their correlation with the disease severity …

First reported from Wuhan, The People's Republic of China, on 31 December 2019, the
ongoing outbreak of a novel coronavirus (2019‐nCoV) causes great global concerns. Based on …

The coronavirus SARS-CoV-2 pandemic became a global health burden. We determined
the susceptibility of SARS-CoV-2 to irradiation with ultraviolet light. The virus was highly …

Background The novel coronavirus SARS-CoV-2 is associated with a severe respiratory
manifestation, COVID-19, and presents a challenge for healthcare systems worldwide. …

Background The Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging
virus involved in cases and case clusters of severe acute respiratory infection in the …

Long-term antibody responses and neutralizing activities in response to SARS-CoV-2
infection are not yet clear. Here we quantify immunoglobulin M (IgM) and G (IgG) antibodies …

The novel human coronavirus EMC (hCoV-EMC), which recently emerged in Saudi Arabia,
is highly pathogenic and could pose a significant threat to public health. The elucidation of …

We have previously shown that Toll‐like receptor (TLR)‐activated murine nonparenchymal
liver cells [(NPC); Kupffer cells (KC), liver sinusoidal endothelial cells (LSEC)] can suppress …

The establishment of viral persistence generally requires evasion of the host CD8 + T cell
response. Here we describe a form of evasion wherein the CD8 + T cells are fully capable of …

Hepatitis B virus (HBV) infection is one of the most frequent causes of chronic liver disease
worldwide. Because recent studies have suggested that Toll‐like receptor (TLR)‐based …